NCT00720577View on ClinicalTrials.gov

Study to Evaluate the Effect of Simvastatin, Losartan and Pioglitazone on Patients With Peripheral Arterial Disease.

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

164

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

July 31, 2007

Study Completion Date

August 31, 2007

Conditions
Peripheral Arterial Disease
Interventions
DRUG

Simvastatin

40 Mg. tablet, 1 tablet daily

DRUG

Losartan

50 mg., tablets, 1 tablet once daily

DRUG

Pioglitazone

30 mg, tablet, 1 tablet once daily

Sponsors

Collaborators (1)

FoxHollow Technologies
All Listed Sponsors
collaborator

FoxHollow Technologies

INDUSTRY

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Medtronic Endovascular

INDUSTRY